News
News
- BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Patients with Previously Treated Unresectable Hepatocellular Carcinoma in China
07/02/2020 / 00:00 - GlobeNewswire - BeiGene Announces Appointment of Angus Grant as Chief Business Executive
07/01/2020 / 13:00 - GlobeNewswire - BeiGene Begins Commercializing XGEVA® (Denosumab) in China
07/01/2020 / 01:30 - GlobeNewswire - Gary C. Kern Joins The Middlefield Banking Company as Chief Information Officer
06/30/2020 / 14:00 - GlobeNewswire - Middlefield Banc Corp. Secures $138 Million in Paycheck Protection Program Loans for 1,259 Ohio-based Small Businesses
06/25/2020 / 14:00 - GlobeNewswire - BeiGene and SpringWorks Announce Presentation of Preclinical Data Combining RAF Dimer Inhibitor Lifirafenib with MEK Inhibitor Mirdametinib and Provide Update on Ongoing Phase 1b/2 Clinical Trial
06/22/2020 / 15:00 - GlobeNewswire - Middlefield Banc Corp. Joins Russell 3000® Index
06/22/2020 / 14:00 - GlobeNewswire - BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination with Chemotherapy in First-Line Advanced Non-Squamous Non-Small Cell Lung Cancer in China
06/19/2020 / 06:27 - GlobeNewswire - CSE Bulletin: Index - CSE Composite Index Quarterly Rebalancing
06/19/2020 / 03:13 - Newsfile Corp - GTX Launches Masks for Kids and UV Wands
06/18/2020 / 15:25 - GlobeNewswire
Real-time